Literature DB >> 23042530

MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.

Timothy Bowen1, Robert H Jenkins, Donald J Fraser.   

Abstract

MicroRNAs are short noncoding RNA regulators that repress synthesis of their targets post-transcriptionally. On average, each microRNA is estimated to regulate several hundred protein-coding genes, and about 60% of proteins are thought to be regulated by microRNAs in total. A subset of these genes, including the key profibrotic cytokine transforming growth factor beta-1 (TGF-β1), exhibits particularly strong levels of post-transcriptional control of protein synthesis, involving microRNAs and other mechanisms. Changes in microRNA expression pattern are linked to profound effects on cell phenotype, and microRNAs have an emerging role in diverse physiological and pathological processes. In this review, we provide an overview of microRNA biology with a focus on their emerging role in diseases typified by organ fibrosis.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23042530     DOI: 10.1002/path.4119

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  57 in total

Review 1.  The role of microRNAs in skin fibrosis.

Authors:  Olubukola Babalola; Andrew Mamalis; Hadar Lev-Tov; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2013-11       Impact factor: 3.017

2.  Transforming Growth Factor-β and Bone Morphogenetic Protein 2 Regulation of MicroRNA-200 Family in Chronic Pancreatitis.

Authors:  Peter Yu; Ka Liu; Xuxia Gao; Harry Karmouty-Quintana; Jennifer M Bailey; Yanna Cao; Tien C Ko
Journal:  Pancreas       Date:  2018-02       Impact factor: 3.327

Review 3.  Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.

Authors:  Juliana Inês Santos; Ana Luísa Teixeira; Francisca Dias; Mónica Gomes; Augusto Nogueira; Joana Assis; Rui Medeiros
Journal:  Tumour Biol       Date:  2014-04-25

Review 4.  TGF-β: the master regulator of fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2016-04-25       Impact factor: 28.314

5.  The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus.

Authors:  A Cayir; R A Ugan; A Albayrak; D Kose; E Akpinar; Y Cayir; H T Atmaca; Z Bayraktutan; M Kara
Journal:  J Endocrinol Invest       Date:  2015-04-07       Impact factor: 4.256

6.  MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway.

Authors:  Ali Hashemi Gheinani; Fiona C Burkhard; Hubert Rehrauer; Catharine Aquino Fournier; Katia Monastyrskaya
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

7.  MicroRNA-21 preserves the fibrotic mechanical memory of mesenchymal stem cells.

Authors:  Chen Xi Li; Nilesh P Talele; Stellar Boo; Anne Koehler; Ericka Knee-Walden; Jenna L Balestrini; Pam Speight; Andras Kapus; Boris Hinz
Journal:  Nat Mater       Date:  2016-10-31       Impact factor: 43.841

8.  Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution.

Authors:  Eric S White; Alberto R Mantovani
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

Review 9.  TGF-β1 Signaling and Tissue Fibrosis.

Authors:  Kevin K Kim; Dean Sheppard; Harold A Chapman
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

10.  MiR-5100 targets TOB2 to drive epithelial-mesenchymal transition associated with activating smad2/3 in lung epithelial cells.

Authors:  Chun-Yan Li; Ya-Hong Wang; Zi-Ying Lin; La-Wei Yang; Sheng-Lan Gao; Tie Liu; Bao-An Zou; Zhan-Chun Pan; Ze-Qing Song; Gang Liu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.